AstraZeneca Withdraws COVID-19 Vaccine Citing 'Commercial Reasons' Amid TTS Side Effect Row

Team Latestly May 08, 2024 03:18 PM IST

UK-based pharmaceutical major AstraZeneca has announced to withdraw its COVID-19 vaccine months after admitting that it can cause rare side effects of blood clotting and low platelet counts.

(The above story first appeared on LatestLY on May 08, 2024 03:18 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).

Tags

AstraZeneca Astrazeneca Covid Vaccine AstraZeneca COVID-19 Vaccine Astrazeneca Covishield Vaccine AstraZeneca Side Effects AstraZeneca Vaccine Astrazeneca Vaccine Side Effects Astrazeneca Withdraw Vaccine Astrazeneca Withdraws Vaccine COVID-19 Vaccine Covishield Side Effects Covishield Vaccine

Follow us on News

You Might Also Like

Needle-Free COVID-19 Vaccine: Hyderabad’s Indian Immunologicals Develops First-of-Its-Kind Intranasal CDO-7N-1 Vaccine To Prevent Coronavirus Infection

Covaxin: Over 30% of Bharat Biotech’s Anti-COVID Vaccine Takers Reported ‘Adverse Events of Special Interest’, Claims BHU Study

What Is VITT? All You Need To Know About Rare Fatal Blood Clotting Disorder Linked to AstraZeneca's COVID-19 Vaccine Covishield

Covishield Linked to Another Rare Fatal Blood Clotting Disorder: Researchers Claim AstraZeneca's COVID-19 Vaccine May Cause VITT After Company's TTS Side Effect Admission

Categories